CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect
Frontiers | The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Schematic presentation of CD40 and CD40L/CD154 expression on DCs and... | Download Scientific Diagram
L'axe CD40-CD40L : implications actuelles et futures en immunologie clinique - ScienceDirect
CD40/CD40L Signaling Pathway - Creative Diagnostics
Frontiers | Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
CD40L and its receptors: the binding of CD40L to CD40, αIIbβ3, α5β1, or... | Download Scientific Diagram
With the High Potential in Cancer Immunotherapy, CD40 Is Triggering Attention - Cusabio
Zooming in on dendritic cells for CD40 agonists | Nature Cancer
CD40 Signaling Pathway
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology
Role of CD40-CD40L in the interaction between T cells and professional... | Download Scientific Diagram
Le rôle biologique de l'interaction du CD40L avec l'intégrine α5β1 des lymphocytes T
Rationale for CD40 pathway blockade in autoimmune rheumatic disorders - The Lancet Rheumatology
Frontiers | CD40L and Its Receptors in Atherothrombosis—An Update
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease | Journal of Cardiovascular Translational Research
HEK-Blue CD40L | CD40L cell-based assay | InvivoGen
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint - ScienceDirect
JCI - Progress on new vaccine strategies against chronic viral infections
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease | Journal of Cardiovascular Translational Research
Cancers | Free Full-Text | Agonistic CD40 Antibodies in Cancer Treatment
The CD40/CD40L costimulatory pathway in inflammatory bowel disease | Gut
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
The CD40/CD40L costimulatory pathway in inflammatory bowel disease | Gut
CD40: Targeting Co-Stimulatory Pathways for Cancer Immunotherapy
